Risk & Leverage

A new partnership between KBRA Analytics and Intex Solutions streamlines CMBS analysis, promising to enhance risk management in volatile economic times.

Estonia's top utility secures key financing for a massive infrastructure upgrade. We decode the risks, rewards, and long-term impact for investors.

Bluerock Acquisition Corp. has raised $150 million. With a sector-agnostic mandate, could this new capital pool target the mining industry?

A new partnership uses AI to analyze imaging, clinical, and molecular data, offering unprecedented accuracy in predicting breast cancer recurrence years later.

NREF's massive capital raise signals strong investor confidence. We dive into what this bold move reveals about the market and income-seeking investors.

The lab outfitter's Nu Aire acquisition fuels record revenue, but integration costs and market volatility paint a complex picture of strategic investment.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

Capital Power unveils a $3B deal with Apollo to buy U.S. gas plants while securing a major deal to power Alberta's AI boom, a bold dual strategy.

The U.S. State Department is deploying a self-learning AI to protect its global diplomatic corps, signaling a new era in federal cybersecurity.

A utility is slashing its carbon footprint by 99.9% not with solar or wind, but with an invisible innovation that fixes the grid from the inside out.

A Japanese genomics leader is using AI and a massive local database to offer personalized cancer risk predictions, a move that could redefine preventative care.